|
Title
|
|
|
|
Rationale and design of REGINA, a phase II trial of neoadjuvant regorafenib, nivolumab, and short-course radiotherapy in stage II and III rectal cancer
| |
|
Author
|
|
|
|
| |
|
Language
|
|
|
|
English
| |
|
Source (journal)
|
|
|
|
Acta oncologica. - Stockholm
| |
|
Publication
|
|
|
|
Stockholm
:
Acta Oncologica
,
2021
| |
|
ISSN
|
|
|
|
0284-186X
[print]
1651-226X
[online]
| |
|
DOI
|
|
|
|
10.1080/0284186X.2020.1871067
| |
|
Volume/pages
|
|
|
|
60
:4
(2021)
, p. 549-553
| |
|
ISI
|
|
|
|
000607245500001
| |
|
Pubmed ID
|
|
|
|
33435735
| |
|
Full text (Publisher's DOI)
|
|
|
|
| |
|
Full text (publisher's version - intranet only)
|
|
|
|
| |
|